• 제목/요약/키워드: AVM protocol

검색결과 2건 처리시간 0.009초

Clinical assessment and management of auricular arteriovenous malformation: retrospective study

  • Kim, Do Gon;Cho, Hyun Geun;Ryu, Jeong Yeop;Lee, Joon Seok;Lee, Seok Jong;Lee, Jong Min;Lee, Sang Yub;Huh, Seung;Kim, Ji Yoon;Chung, Ho Yun
    • 대한두개안면성형외과학회지
    • /
    • 제22권3호
    • /
    • pp.141-147
    • /
    • 2021
  • Background: Arteriovenous malformation (AVM) which is a high-blood-flow lesion with connections between arteries and veins without an intervening capillary bed, is difficult to manage. The ear is the second most common site of extracranial AVM. However, studies regarding the management of this condition remain lacking. The purpose of this study was to share managing experiences in our center and to investigate the treatment effect through a retrospective analysis of cases. Methods: Among 265 patients with AVM treated in our vascular anomalies center between January 2008 and January 2021, 10 patients with auricular AVM were included in the study to investigate the lesion distribution, clinical stage, and treatment methods by performing a retrospective evaluation. Results: Among 10 patients, five patients had AVMs distributed in the upper half of the ear, one patient in the lower half of the ear, and four patients in whole ear, respectively. Seven patients had Schobinger stage II, and three had stage III. One patient received surgical treatment only, four patients received sclerotherapy only, and five patients received both surgical treatment and sclerotherapy. The posttreatment status was checked as controlled in two patients, improved in seven patients, persistent in one patient. There were no worsening patients. Conclusion: Auricular AVM is a disease that is difficult to manage by one specific department, thus requiring a collaborative management effort from multidisciplinary team.

원형질체 융합에 의한 Avermectina B_{1a} 고생산성 Streptomyces avermitilis 균주 개발 (Development of High-yielding Mutants of Streptomyces avermitilis for Avermectin B_{1a} Production through Protoplast Fusion.)

  • 김경희;송성기;정연호;정용섭;전계택
    • 한국미생물·생명공학회지
    • /
    • 제32권2호
    • /
    • pp.101-109
    • /
    • 2004
  • Streptomyces avermitilis가 생산하는 이차대사산물인 avermectin $B_{la}$ (AVM $B_{la}$ /)의 생산성을 향상시키고자, 고생산성 균주를 융합파트너로 이용하여 원형질체 융합에 필요한 기본 실험조건을 확립하였고, 대량 선별시스템을 이용하여 다양한 융합균주들을 선별하였다. 특별한 표지인자가 없는 경우에도 원형질체 융합에 의해 유전자재조합체들을 선별할 수 있는 방법을 개발하였다. 즉 고생산성 균주의 원형질체(L-isoleucine유사체인 O-methylthreoiune또는 azaleucine에 대한 저항성 변이주의 원형질체를 치사율이 약 95%정도 되도록 UV나 NTG로 각 원형질체를 돌연변이시킨 후, 융합을 시도하여 재생된 변이주를 원형질 융합된 유전자재조합체로 간주하는 방법을 고안하였다. 돌연변이원으로 UV를 이용할 경우 대부분의 유전자재조합 균주들의 AVM $B_{la}$ 생산성이 융합 모균주들에 비해 높게 나타났으며, 주목할 만하게도 최고 3배 정도 향상된, 거의 산업용 균주의 생산성을 갖는 균주들을 선별할 수 있었다.